Form 4: Foghorn Therapeutics Executive Carlos Costa Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Carlos Costa, Chief People Officer of Foghorn Therapeutics, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

  • Carlos Costa, Chief People Officer of Foghorn Therapeutics Inc., executed transactions involving the company's common stock.
  • On September 16, 2024, Costa exercised options to acquire 400 shares at $3.72 per share and sold 400 shares at $10.00 per share.
  • On September 17, 2024, Costa exercised options to acquire 10,272 shares at $3.72 per share and sold 10,272 shares at a weighted average price of $10.04 per share.
  • These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 11, 2024.
  • Following these transactions, Costa directly owns 0 shares of common stock and 87,976 stock options.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine transactions. The sentiment is neutral as it reflects scheduled sales under a pre-existing plan.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. The use of 10b5-1 trading plans allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.

Key Dates

DateDescription
March 11, 2024Date the reporting person adopted the Rule 10b5-1 trading plan
September 16, 2024Date of first reported transaction (exercise and sale of 400 shares)
September 17, 2024Date of second reported transaction (exercise and sale of 10,272 shares)
September 18, 2024Date of Form 4 filing
February 12, 2029Expiration date of the stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.